Prospective evaluation of hematological parameters in preoperative renal cell cancer patients.

Published in: BMC urology (2022)

The preoperative FAR is an independent prognostic factor of OS in renal cancer patients. A FAR > 0.114 was significantly related to decreased survival in renal cancer patients. In addition, the platelet-lymphocyte ratio seems to be related to OS, as well as FAR. Further studies are required on this subject.

Keyphrases

prognostic factors
patients undergoing
single cell
stem cells
cell therapy
peripheral blood